Development of Non-Opioid Analgesics for Acute Pain; Draft Guidance for Industry: Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 9, 2022
February 16, 2022
713b2eb7-8a4f-499d-a0e2-6ff44a5ecff9
Related Documents
Opioid Analgesic Drugs: Considerations for Benefit-Risk Assessment Framework Guidance for Industry
Guidance DocumentJune 20, 2019Center for Drug Evaluation and Research
Assessment of Pressor Effects of Drugs Guidance for Industry: Draft Guidance for Industry
Guidance DocumentFebruary 3, 2022Center for Drug Evaluation and Research
Development of Non-Opioid Analgesics for Chronic Pain: Draft Guidance for Industry
Guidance DocumentSeptember 10, 2025Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox